01/12/2019
Canine Degenerative Myelopathy – Some Success at Last.
Australian veterinarian, Dr Harry Corbett, has recently had success in treating dogs with the symptoms of Canine Degenerative Myelopathy. Many dogs have been treated, generally resulting in greatly improved mobility, playfulness and interactivity. Success is due a capsule developed by Dr Corbett (prefers to be referred to as Harry) that is a unique melding of botanical extracts. The capsule(s) is taken daily and added into a reasonably standard treatment regimen.
Initial success was first observed in April 2017 (“Penny” a 15 year old Pug on the verge of requiring wheels who within 2 weeks had use of her back legs) meaning that many of the early successes (including 2 other Pugs, a German Shepherd, a Dobermann and many mixed breeds) have since died of old age: “Neo” the Pug was about 19 and Remy, Staffie Cross, 17. However, testimonies from their owners show convincingly that the treated pets had a greatly improved life. Almost all of these patients came from Harry’s practice’s client base.
In old dogs with mobility problems we have seen a great improvement in the general demeanour of the majority of treated pets when the capsules are added to standard treatment regimens of anti-inflammatories plus Pentosan and analogues with owners frequently claiming that they have “a new dog”.
Harry recently retired from general veterinary practice and has opened a facility to concentrate on the diseases of ageing, especially CDM as it is thought to be the canine equivalent of Motor Neurone Disease in the human. The future of the facility (probably the first of its type in the world, run as a charity) and the continued research of Harry will be dependent upon donations made by owners of affected pets and also donations made by those who have experienced the devastation of CDM and those donating in the hope that the research may lead to clues as to how to improve the lives of people with MND (often referred to as Lou Gehrig’s Disease). Much work has to be done to determine why it is that some dogs improve almost miraculously yet others do not – certainly the results obtained so far indicate that any notion CDM is simply due to genetic mutations needs to be vigorously challenged.
Up to this point Harry’s research, which effectively extends back decades, has been entirely self-funded with the capsules being provided gratis; a gift that we can no longer provide.
As we start seeing new cases at SEARCh we will follow their progress. Generally owners report an improvement in brightness, playfulness and interactivity within the first 2 weeks and then an improvement in mobility with greater control of their back legs.
Go to this link (the site is a “Work in Progress”) to read of our work and the improvements made in patients. Apologies, it is pretty rudimentary at the moment but things will improve. We will try to reply to queries promptly.
Serendipity Enterprises Ageing Research Charity (SEARCh) is a not-for-profit organisation that provides Support and Assistance to those with the degenerative diseases associated with Ageing.
